Arrowhead Research | ARWR - Ebitda

سعر السهم
75.35
التغيير اليومي
0.42 0.56%
شهريا
23.16%
سنويا
476.95%
Q2 التوقعات
73.25




Ebitda تغيير تاريخ
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Incyte USD 367.97M 46.53M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
Merck USD 6.3B 2.09B 2025-12
Moderna USD -790M 582M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 5.3B 530M 2026-03
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
TG Therapeutics USD 32.69M 5M 2025-09
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vertex Pharmaceuticals USD 1.39B 48.8M 2025-12
Xencor USD -51.05M 55.28M 2025-12